Aeterna Zentaris to Announce Second Quarter 2013 Financial and Operating Results on August 8, 2013

MONTREAL, Aug. 1, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its second quarter 2013 financial and operating results after market close on Thursday, August 8, 2013. The Company will host a conference call to discuss these results on Friday, August 9, 2013, at 8:30 a.m., Eastern Time.

Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Newsroom" section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company's website for a period of 30 days.

About Aeterna Zentaris

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval. For more information, visit www.aezsinc.com.

SOURCE: Aeterna Zentaris Inc.

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
[phone] ext. 265
[email protected]

Media Relations
Paul Burroughs
Director of Communications
[phone] ext. 406
[email protected]